Brussels, March 20, 2024, 08:30 CET - Regulated information
In line with Belgian transparency legislation (Law of May 2, 2007), DME Advisors
and DME Capital Management recently sent to Solvay the following transparency
notification indicating that they crossed the threshold of 5%.
The notification, dated March 15, 2024, contains the following information:
* Reason for the notification: acquisition or disposal of voting securities or
voting rights Notified by: A parent undertaking or a controlling person
* Date on which the threshold is crossed: March 8, 2024
* Threshold of direct voting rights crossed: 5% upwards
* Denominator: 105,876,416
* Full chain of controlled undertakings through which the holding is
effectively held: DME Advisors, LP and DME Capital Management, LP are
controlled by DME Advisors GP, LLC. DME Advisors GP, LLC is controlled by
David Einhorn.
* Additional information: DME Advisors, LP and DME Management LP are the
discretionary investment managers and exercise the voting rights at their
discretion in the absence of specific instructions.
* Persons subject to the notification requirement:
Name Address (for legal entities)
David Einhorn 140 East 45th Street, 24th Floor, New York, NY
10023, USA
DME Advisors GP, LLC Corporation Trust Center, 1209 Orange Street,
Wilmington, DE 19801, USA
DME Capital Management, LP Corporation Trust Center, 1209 Orange Street,
Wilmington, DE 19801, USA
DME Advisors, LP Corporation Trust Center, 1209 Orange Street,
Wilmington, DE 19801, USA
Â